Telesis Bio, Inc.
TBIO
$0.325
$0.0196.21%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 6.98M | 5.56M | 8.65M | 6.32M | 9.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.98M | 5.56M | 8.65M | 6.32M | 9.47M |
| Cost of Revenue | 2.23M | 2.57M | 2.96M | 7.63M | 3.02M |
| Gross Profit | 4.75M | 3.00M | 5.69M | -1.31M | 6.45M |
| SG&A Expenses | 7.17M | 9.00M | 9.07M | 9.36M | 9.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.07M | 15.69M | 16.62M | 17.29M | 17.35M |
| Operating Income | -6.09M | -10.12M | -7.97M | -10.97M | -7.88M |
| Income Before Tax | -17.68M | -10.62M | -8.28M | -11.12M | -8.13M |
| Income Tax Expenses | 3.00K | 14.00K | 4.00K | 3.00K | 6.00K |
| Earnings from Continuing Operations | -17.69M | -10.63M | -8.29M | -11.12M | -8.13M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.69M | -10.63M | -8.29M | -11.12M | -8.13M |
| EBIT | -6.09M | -10.12M | -7.97M | -10.97M | -7.88M |
| EBITDA | -5.44M | -9.49M | -7.44M | -10.46M | -7.37M |
| EPS Basic | -0.61 | -0.37 | -0.28 | -0.37 | -0.28 |
| Normalized Basic EPS | -0.13 | -0.22 | -0.17 | -0.23 | -0.17 |
| EPS Diluted | -0.61 | -0.37 | -0.28 | -0.37 | -0.28 |
| Normalized Diluted EPS | -0.13 | -0.22 | -0.17 | -0.23 | -0.17 |
| Average Basic Shares Outstanding | 30.01M | 29.95M | 29.77M | 29.66M | 29.56M |
| Average Diluted Shares Outstanding | 30.01M | 29.95M | 29.77M | 29.66M | 29.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
